David Charles Lubner Point Biopharma Global Inc. (PNT) insider trading activity

David Charles Lubner is Director of POINT Biopharma Global Inc.. Currently has a direct ownership of 0 shares of PNT, which is worth approximately $0. The most recent transaction as insider was on Dec 27, 2023, when has been sold 3,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

David Charles Lubner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 27 2023	SELL Sale (or disposition) back to the issuer	-	3,600 Reduced 100.0%	0 Common Stock
Dec 26 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	35,400 Reduced 90.77%	3,600 Common Stock
Nov 23 2022	BUY Open market or private purchase	$24,660 $6.85 p/Share	3,600 Added 50.0%	3,600 Common Stock

Also insider at

VOR

Vor Biopharma Inc. Healthcare

GMTX

Gemini Therapeutics, Inc. Healthcare

Director

DYN

Dyne Therapeutics, Inc. Healthcare

ACLX

Arcellx, Inc. Healthcare

CRGX

CARGO Therapeutics, Inc.

DCL